Shares of ManpowerGroup Inc. tumbled to a 13-year low Thursday, after the jobs-placement company suffered a rare earnings miss as uncertainty surrounding tariffs led to lower demand from employers. To ...
The United States pays undeniably high prices for brand-name drugs. But when it comes to generics — the cheaper copycat medicines that now fill nine out of every 10 prescriptions in America — the ...
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use has recommended granting a marketing authorisation for Palbociclib Viatris (palbociclib, Viatris Limited) for the ...
WESTON, Fla., April 10, 2026 /PRNewswire/ - Apotex Corp. today announced it has received the first U.S. Food and Drug Administration (FDA) Tentative Approval for its Abbreviated New Drug Application ...
A flood of cheap copies of Novo Nordisk A/S’ blockbuster weight-loss drug in India is already reshaping the country’s fast-growing obesity medicine market, showing how quickly the patent cliff will ...
Generic dapagliflozin is indicated to lower heart failure hospitalization risk in type 2 diabetes with established cardiovascular disease or multiple risk factors, and to improve glycemic control ...
TORONTO — Anne Welch worked a physically demanding job at her local SPCA — lifting pets, cleaning kennels and walking dogs — until she retired at age 71. With the loss of that physical activity, ...
As modern .NET applications grow increasingly reliant on concurrency to deliver responsive, scalable experiences, mastering asynchronous and parallel programming has become essential for every serious ...
Two-time cancer survivor Sherman McDaniel may be in fragile health, but she is sticking to her vow: “I’m not going anywhere until Generic Theater has a permanent home. Until then, I will not die.” ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Ozempic and Wegovy are injectable prescription weight-loss medicines made by Danish ...
Hosted on MSN
Ozempic goes generic — but not in the US
A drug that helped turn Novo Nordisk into Europe's most valuable company is about to lose its monopoly grip across much of the globe. Patent protections on semaglutide—sold as Ozempic for diabetes and ...
At least a dozen large Indian drugmakers are set to roll out copies of Novo Nordisk A/S’s blockbuster weight-loss drugs as soon as the patent expires Friday, crashing prices in the country with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results